Ensysce Biosciences (ENSCW) Change in Taxes (2018 - 2020)
Ensysce Biosciences (ENSCW) reported Change in Taxes of -$244469.0 for Q4 2020, down 477.45% year-over-year from $64768.0 in Q1 2020, and down 192.51% quarter-over-quarter from $264248.0 in Q3 2020.
Ensysce Biosciences (ENSCW) Change in Taxes (2018 - 2020) Analysis & Trends
Ensysce Biosciences (ENSCW) has 3 years of Change in Taxes data on file, last reported at -$244469.0 in Q4 2020.
- Change in Taxes for Q4 2020 came in at -$244469.0, down 477.45% year-over-year; the trailing twelve-month figure through Dec 2020 was -$118792.0 (down 271.64% YoY), and the FY2020 annual result was -$118792.0, down 271.64% from the prior year.
- Change in Taxes declined to -$244469.0 in Q4 2020 per ENSCW's latest filing, from $264248.0 in the prior quarter.
- Over five years, Change in Taxes peaked at $264248.0 in Q3 2020 and troughed at -$244469.0 in Q4 2020.
- A 3-year average of -$26774.2 and a median of -$48928.0 in 2019 frame the typical range for Change in Taxes.
- The sharpest annual moves came in 2019 and 2020: Change in Taxes slumped 32110.91% in 2019, then jumped 343.51% in 2020.
- A 3-year view of Change in Taxes shows it stood at -$167239.0 in 2018, then surged by 138.73% to $64768.0 in 2019, then plunged by 477.45% to -$244469.0 in 2020.
- Business Quant data shows ENSCW's Change in Taxes at -$244469.0 in Q4 2020, $264248.0 in Q3 2020, and -$63946.0 in Q2 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ensysce Biosciences | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -244,469.00 |
| Dec 31, 2020 | -244,469.00 |
| Sep 30, 2020 | 264,248.00 |
| Sep 30, 2020 | 264,248.00 |
| Jun 30, 2020 | -63,946.00 |
| Jun 30, 2020 | -63,946.00 |
| Mar 31, 2020 | -74,625.00 |
| Mar 31, 2020 | -74,625.00 |
| Dec 31, 2019 | 64,768.00 |
| Dec 31, 2019 | 64,768.00 |
| Sep 30, 2019 | -108,517.00 |
| Sep 30, 2019 | -108,517.00 |
| Jun 30, 2019 | -33,910.00 |
| Jun 30, 2019 | -33,910.00 |
| Mar 31, 2019 | 45,695.00 |
| Mar 31, 2019 | 45,695.00 |
| Dec 31, 2018 | -167,239.00 |
| Dec 31, 2018 | -167,239.00 |
| Sep 30, 2018 | 339.00 |
| Sep 30, 2018 | 339.00 |